Monteris Medical
Plymouth, US · Founded 2012 · Delaware corporation · 129 employees on LinkedIn · 2 known investors
Find your way into Monteris Medical
94 people in our graph share verified history with the Monteris Medical team — schools, employers, funds. One of them is your warm intro.
Miles Reidyunlockedknows JAMES ERICKSON · together at Sears Holdings (overlapped)
×4knows the team · via Sears Holdings
knows the team · via Toys R Us
×5knows the team · via Long Island University
knows the team · via jcpenney
Monteris develops minimally invasive laser ablation technology (LITT) used to treat brain conditions including oncology tumors and drug-resistant epilepsy. It focuses on generating prospective multi-center clinical evidence to support physicians treating these patients.
Founders & leadership
JE
JAMES ERICKSONinExecutiveJames Erickson held leadership positions in retail for over eight years and has experience building analytical and scheduling tools.
ME
MARTIN EMERSONExecutive
JS
John SchellhorninPresident & CEO2012–2016John Schellhorn spent over a decade in executive and leadership roles at medical device companies, including global responsibilities at Boston Scientific and experience building new market entry strategies across multiple international markets. He has held positions leading strategy, operations, and commercialization at several MedTech firms, with involvement in developing and commercializing minimally invasive and digital health technologies.
RK
Robert K DavidsonExecutive
Board
RE
GB
Gregory BarrettBoard director
DC
Daniel ColeBoard director
MS
MATTHEW STROBECKBoard director
JR
James RichardsonBoard director
JR
JAMES REINSTEINinNon Executive Member of the Board of Directors2015–2023Executive Officer, Director at Conformal Medical
GB
Gary BantleBoard director
PM
Patrick MorandBoard director
Investors · 2
Funding
SEC filings, press & company announcements$110.5M disclosed across 8 rounds · 2014–2026
- $28MSeries EMar 2026 · 3 sourcesSource ↗
▶$13.7MraisedSep 2022 · 3 investors · Other Health CareRule 506(b)
▶$13.7MraisedSep 2022 · 3 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Kirk NielsenDirector
- James ReinsteinDirector
- Martin EmersonExecutive Officer, Director
- Joseph BillerDirector
- James EricksonExecutive Officer
- Richard EmmittDirector
- Matthew StrobeckDirector
- Offering amount
- $13.7M
- Amount sold
- $13.7M
- First sale
- Sep 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$9MraisedSep 2020 · 1 investors · Other Health CareRule 506(b)
▶$9MraisedSep 2020 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Matthew StrobeckDirector
- Bill HoffmanDirector
- Joe BillerDirector
- Kirk NielsenDirector
- James ReinsteinDirector
- Richard EmmittDirector
- James EricksonExecutive Officer
- Martin EmersonExecutive Officer, Director
- Offering amount
- $30M
- Amount sold
- $9M
- First sale
- Aug 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.5MraisedMar 2020 · 9 investors · Other Health CareRule 506(b)
▶$2.5MraisedMar 2020 · 9 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- James EricksonExecutive Officer
- Bill HoffmanDirector
- Kirk NielsenDirector
- Joe BillerDirector
- James ReinsteinDirector
- Richard EmmittDirector
- Matthew StrobeckDirector
- Martin EmersonExecutive Officer, Director
- Offering amount
- $6.1M
- Amount sold
- $2.5M
- First sale
- Mar 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$7MraisedMar 2019 · 9 investors · Other Health CareRule 506(b)
▶$7MraisedMar 2019 · 9 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Kirk NielsenDirector
- Joe BillerDirector
- James ReinsteinDirector
- Martin EmersonExecutive Officer, Director
- Bill HoffmanDirector
- James EricksonExecutive Officer
- Richard EmmittDirector
- Matthew StrobeckDirector
- Offering amount
- $12.2M
- Amount sold
- $7M
- First sale
- Jan 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$26.6MraisedJun 2017 · 10 investors · Other Health CareRule 506(b)
▶$26.6MraisedJun 2017 · 10 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- RICHARD EMMITTDirector
- MARTIN EMERSONExecutive Officer, Director
- JAMES ERICKSONExecutive Officer
- JAMES REINSTEINDirector
- MATTHEW STROBECKDirector
- Offering amount
- $26.6M
- Amount sold
- $26.6M
- First sale
- May 2017
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
▶$6.8MraisedNov 2016 · 2 investors · Other Health CareRule 506(b)
▶$6.8MraisedNov 2016 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- RICHARD EMMITTDirector
- JAMES ERICKSONExecutive Officer
- GREGORY BARRETTDirector
- James RichardsonDirector
- DANIEL COLEDirector
- MARTIN EMERSONExecutive Officer, Director
- JAMES REINSTEINDirector
- MATTHEW STROBECKDirector
- Offering amount
- $10M
- Amount sold
- $6.8M
- First sale
- Nov 2016
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
▶$16.9MraisedNov 2014 · 4 investors · BiotechnologyRule 506(b)
▶$16.9MraisedNov 2014 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- John SchellhornExecutive Officer, Director, Promoter
- Robert K DavidsonExecutive Officer
- Gregory BarrettDirector
- Gary BantleDirector
- Patrick MorandDirector
- Kevin McGarryDirector
- James RichardsonDirector
- Daniel ColeDirector
- Offering amount
- $25.1M
- Amount sold
- $16.9M
- First sale
- Nov 2014
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlap
Rf Surgical22 shared keywordsMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.
Alumis14 shared keywordsAlumis is a clinical-stage biopharmaceutical company developing a late-stage portfolio of targeted therapies for immune-mediated diseases. It focuses on small-molecule drug discovery and development in immunology and inflammation.
ADP13 shared keywordsADP provides cloud-based human capital management solutions that integrate payroll, HR, talent management, time and attendance, tax, and benefits administration for businesses globally. The company serves as a comprehensive provider of HCM software and business outsourcing services with analytics and compliance expertise.
Companies competing with Monteris Medical for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Monteris Medical do?
- Monteris develops minimally invasive laser ablation technology (LITT) used to treat brain conditions including oncology tumors and drug-resistant epilepsy. It focuses on generating prospective multi-center clinical evidence to support physicians treating these patients.
- Who are Monteris Medical's investors?
- Monteris Medical's investors include The Vertical Group, Vensana Capital.
- How much funding has Monteris Medical raised?
- Monteris Medical has disclosed $110.5M raised across 8 rounds.
- Where is Monteris Medical headquartered?
- Monteris Medical is headquartered in Plymouth, US.